Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
John Dent a Department of Gastroenterology, Hepatology, and
General Medicine, Royal Adelaide Hospital, Adelaide, SA 5000, Australia, b Department
of General Practice and Primary Care, Guy's, King's, and St Thomas'
School of Medicine, London SE11 6SP , c Division of
Gastroenterology and Hepatology, Department of Medicine, Northwestern
University Medical School, Chicago, IL 60611-3008, USA, d Department of
Medicine, University of Sydney, Nepean Hospital, Penrith, PO Box 63, NSW 2751, Australia
Correspondence to: R Jones
roger.jones@kcl.ac.uk
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Gastro-oesophageal reflux disease is a potentially serious condition that can greatly reduce patients' quality of life and carries a risk of oesophagitis and complications.1 It is a common condition and a considerable burden on healthcare resources. Most patients are managed in general practice, and effective management of the disease remains a challenge. Guidelines produced in Europe, 2 3 the United States,4 and Canada5 do not give consistent recommendations.
| Table Removed (Available Only in the Full Text) |
| |
Methods |
|---|
An international multidisciplinary workshop was held in
Genval, Belgium, in 1999 to evaluate the literature on
gastro-oesophageal reflux disease, including numerous
reviews,6-8 in the light of clinical
experience.9 Participants voted on their level of support
and the strength of the evidence for a series of statements relevant to
the management of the disease. In this article we summarise the
conclusions of the Genval workshop and present an overview of the
latest thinking on the management of gastro-oesophageal reflux disease
relevant to general practice. We also
Read all Rapid Responses